Lucid Diagnostics Inc (LUCD) Provides Business Update, Reports Prelim Q4
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/5/2026
- S&P 500, Dow at record highs as Mideast hopes offset SpaceX, AMD drag
- SpaceX tumbles amid AI spending concerns; Musk outlines $1 trillion revenue target
- AMD shares slide 8% after Musk flags plans to buy Nvidia chips for SpaceX
- AZN spikes 6% after report it denies AstraZeneca-BMS merger talks
- New report warns China transceiver ban would hurt U.S. AI giants
- Nutanix to cut 5% of workforce, expects up to $43M in charges
- Opendoor posts Q2 revenue rise as net loss widens year over year
- Walmart dips after Oppenheimer downgrades shares on difficult short-term setup
- Dave & Buster's names CFO Darin Harper as new CEO
- Dow, S&P 500 close at record on AI-linked earnings, Mideast deal hopes
- After-Hours Movers: SPCX, AMD, ANET, PINS, APPS, UPST, ZETA, BKNG, LCID, CPNG, MTCH
- After-Hours Stock Movers: PLTR, SNAP, ON, ICHR, WGS, WHR
- After-Hours Stock Movers: AAPL, AMZN, COIN, RBLX, RDDT, AXTI, FND, WU, GDDY
- After-Hours Stock Movers: META, MSFT, CMG, SBUX, CVNA, LRCX, FTNT, QCOM, TDOC
- After-Hours Stock Movers: F, BE, STX, WDC, KLAC, SWKS, NXPI, CSGP, ENPH
Lucid Diagnostics Inc (LUCD) PT Lowered to $12 at Canaccord Genuity
March 29, 2022 7:40 AM EDTCanaccord Genuity analyst Kyle Mikson lowered the price target on Lucid Diagnostics Inc (NASDAQ: LUCD) to $12.00 (from $18.00) while maintaining a Buy rating.
... MoreLucid Diagnostics Inc (LUCD) PT Lowered to $7 at Needham & Company
March 29, 2022 6:31 AM EDTNeedham & Company analyst Mike Matson lowered the price target on Lucid Diagnostics Inc (NASDAQ: LUCD) to $7.00 (from $13.00) while maintaining a Buy rating after the company missed fourth-quarter revenue consensus.
The analyst commented, "LUCD missed consensus revenue in 4Q21. EsoGuard test volume grew 49% sequentially... More
